Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Gritstone Oncology Inc | 6 | 1 | 2 | 0 | €0.42 | €3.68 | 785.501% |
| Cara Therapeutics Inc. | 10 | 6 | 0 | 2 | €0.32 | €4.61 | 1357.612% |
| Aspira Womens Health Inc. | 1 | 1 | 1 | 0 | €0.85 | €4.99 | 487.341% |
| Bluebird Bio Inc. | 7 | 6 | 3 | 0 | €0.56 | €5.47 | 874.093% |
| Karyopharm Therapeutics Inc. | 8 | 1 | 3 | 0 | €0.71 | €5.49 | 673.732% |
| Trevena Inc. | 2 | 23 | 0 | 3 | €0.15 | €6.48 | 4136.601% |
| Bayer AG ADR | 1 | 1 | 0 | 0 | €7.05 | €7.00 | -0.709% |
| Fate Therapeutics Inc. | 4 | 3 | 1 | 0 | €3.22 | €7.31 | 127.384% |
| AEterna Zentaris Inc. | 2 | 22 | 0 | 2 | €1.87 | €8.51 | 355.096% |
| Glycomimetics Inc. | 3 | 6 | 0 | 3 | €0.15 | €9.13 | 5909.605% |
| Inotiv Inc. | 3 | 1 | 0 | 0 | €1.26 | €10.66 | 746.167% |
| Uniqure B.V. | 1 | 2 | 0 | 0 | €5.46 | €11.00 | 101.539% |
| Cellectar BioSciences Inc. | 5 | 4 | 0 | 0 | €1.98 | €11.09 | 460.182% |
| Syros Pharmaceuticals Inc. | 9 | 1 | 3 | 0 | €1.47 | €12.01 | 716.701% |
| Cyclacel Pharmaceuticals Inc. | 2 | 8 | 0 | 0 | €0.22 | €14.66 | 6565.591% |
| Moleculin Biotech Inc | 3 | 25 | 0 | 2 | €0.41 | €18.42 | 4393.659% |
| Palisade Bio Inc. | 3 | 1 | 0 | 0 | €0.34 | €21.06 | 6072.333% |
| Sage Therapeutics Inc. | 5 | 2 | 0 | 0 | €7.11 | €21.44 | 201.354% |
| Rocket Pharmaceuticals Inc | 2 | 1 | 0 | 0 | ? | €32.00 | 92.019% |
| Agenus Inc. | 4 | 2 | 1 | 0 | €0.41 | €37.02 | 8846.834% |
| Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | €1.04 | €50.00 | 4712.320% |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €36.20 | €50.00 | 38.122% |
| Larimar Therapeutics Inc. | 2 | 3 | 0 | 0 | €7.05 | €58.50 | 729.787% |
| Bristol-Myers Squibb | 7 | 3 | 0 | 1 | €44.30 | €67.64 | 52.701% |
| Mirati Therapeutics Inc. | 1 | 10 | 0 | 0 | €53.84 | €78.43 | 45.666% |